Cytocure Medicare Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 17-06-2024
- Paid Up Capital ₹ 0.10 M
as on 17-06-2024
- Company Age 6 Year, 4 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 6.60 Cr
as on 17-06-2024
- Revenue 70.43%
(FY 2023)
- Profit 140.13%
(FY 2023)
- Ebitda 34.53%
(FY 2023)
- Net Worth 555.27%
(FY 2023)
- Total Assets 68.29%
(FY 2023)
About Cytocure Medicare
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹6.60 Cr.
Jay Anam, Praveen Kammar, Nilesh Chordiya, and Three other members serve as directors at the Company.
- CIN/LLPIN
U85300MH2019PTC319108
- Company No.
319108
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Jan 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Cytocure Medicare?
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Praveen Kammar  | Director | 07-Jan-2019 | Current |
| Nilesh Chordiya | Additional Director | 17-Nov-2022 | Current |
| Jay Anam | Director | 07-Jan-2019 | Current |
| Sanket Mehta | Director | 07-Jan-2019 | Current |
| Chetan Anchan | Director | 17-Mar-2020 | Current |
| Jageshwar Pandey | Director | 07-Jan-2019 | Current |
Financial Performance of Cytocure Medicare.
Cytocure Medicare Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 70.43% increase. The company also saw a substantial improvement in profitability, with a 140.13% increase in profit. The company's net worth Soared by an impressive increase of 555.27%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cytocure Medicare?
In 2023, Cytocure Medicare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Pred Healthcare Solutions LlpActive 3 years 5 monthsJay Anam, Praveen Kammar and 4 more are mutual person
- Specialty Surgical Oncology LlpActive 3 years 4 months
Jay Anam, Praveen Kammar and 4 more are mutual person
- Spj Onco Care Private LimitedActive 6 years 1 month
Jay Anam, Praveen Kammar and 3 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 29 Nov 2023 | ₹1.02 Cr | Open |
Others Creation Date: 28 Dec 2022 | ₹3.22 M | Open |
Others Creation Date: 30 Sep 2021 | ₹2.00 Cr | Open |
How Many Employees Work at Cytocure Medicare?
Cytocure Medicare has a workforce of 28 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cytocure Medicare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cytocure Medicare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
